✦ LIBER ✦

Toxicity and preliminary results of combined radiation and chemotheraphy in the treatment of Hodgkin's disease (a randomized study of cancer and leukemia group B)

✍ Scribed by Sameer Rafla; Morton Coleman; Thomas Pajak; Vincent Vinciguerra

Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 185 KB
Volume: 5
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(79)90450-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of combined radiatio

Preliminary results of combined radiation and chemotherapy in the treatment of Hodgkin's disease (A randomized study of cancer and leukemia group B)

✍ Sameer Rafla; Morton Coleman; Thomas Pajak; Vincent Vinciguerra 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Preliminary results of combined radiatio

Preliminary results of combined radiation and chemotherapy in the treatment of small cell carcinoma of the lung (a randomized study of cancer and leukemia group b)

✍ Walter Eaton; Herbert Maurer; Arvin Glicksman; Thomas Pajak; Lawrence Reinstein 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The superiority of CCNU in the treatment

The superiority of CCNU in the treatment of advanced hodgkin's disease: Cancer and leukemia group b study

✍ Heine H. Hansen; Oleg S. Selawry; Thomas F. Pajak; Charles L. Spurr; Geoffrey Fa 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

A combined modality approach to the trea

A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial

✍ Michael J. O'Connell; Dr. Peter H. Wiernik; Kirkland C. Brace; Roger W. Byhardt; 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 789 KB

Long term follow-up of combination chemo

Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease. A cancer and acute leukemia group B study

✍ Barth Hoogstraten; Oliver Glidewell; James F. Holland; Johannes Blom; Leon Stutz 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

Treatment of refractory Hodgkin's diseas

Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin study group

✍ Wolfgang Hiddemann; Norbert Schmitz; Michael Pfreundschuh; Karl-Heinz Pflüger; J 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB